|
ZNF12 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.99200722162641E-16 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.33529973137081E-10 |
| Normal-vs-Stage2 |
6.500100E-03 |
| Normal-vs-Stage3 |
2.819900E-03 |
| Normal-vs-Stage4 |
1.266290E-02 |
| Stage1-vs-Stage2 |
7.874600E-01 |
| Stage1-vs-Stage3 |
1.637040E-01 |
| Stage1-vs-Stage4 |
2.881800E-01 |
| Stage2-vs-Stage3 |
2.978800E-01 |
| Stage2-vs-Stage4 |
3.664200E-01 |
| Stage3-vs-Stage4 |
9.079600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.87148124459236E-14 |
| Normal-vs-AfricanAmerican |
4.50640000004832E-06 |
| Normal-vs-Asian |
3.009200E-01 |
| Caucasian-vs-AfricanAmerican |
8.277600E-01 |
| Caucasian-vs-Asian |
3.513400E-01 |
| AfricanAmerican-vs-Asian |
4.075000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.71307412699662E-12 |
| Normal-vs-Female |
4.98579999508308E-08 |
| Male-vs-Female |
6.825800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.028000E-04 |
| Normal-vs-Extreme_Weight |
4.72650000027386E-07 |
| Normal-vs-Obese |
3.70680000028045E-08 |
| Normal-vs-Extreme_Obese |
7.769600E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.029200E-01 |
| Normal_Weight-vs-Obese |
2.011200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.705000E-01 |
| Extreme_Weight-vs-Obese |
5.273400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.881400E-01 |
| Obese-vs-Extreme_Obese |
4.343400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.242100E-04 |
| Normal-vs-Age(41-60Yrs) |
7.48290318597356E-14 |
| Normal-vs-Age(61-80Yrs) |
2.76070000193585E-08 |
| Normal-vs-Age(81-100Yrs) |
1.493020E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.284200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.581200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.665000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.431900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.075600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.092800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
2.508000E-02 |
| Normal-VS-KIRP CIMP |
2.180600E-01 |
| Normal-VS-Unclassified PRCC |
4.392100E-04 |
| Type1 PRCC-VS-Type2 PRCC |
8.18399999991115E-07 |
| Type1 PRCC-VS-KIRP CIMP |
4.000500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.634600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.623200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.193640E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.920190E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.464400E-03 |
| Normal-vs-N1 |
1.423080E-03 |
| Normal-vs-N2 |
7.242800E-03 |
| N0-vs-N1 |
1.763010E-01 |
| N0-vs-N2 |
7.939200E-01 |
| N1-vs-N2 |
7.044400E-01 |
|
|
